SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
the Securities Exchange Act of 1934 (Amendment No. )




Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2025 | $20.00 | Buy | Goldman |
| 8/25/2025 | $23.00 | Buy | BTIG Research |
| 8/25/2025 | $18.00 | Overweight | Piper Sandler |
| 8/25/2025 | $19.00 | Buy | Jefferies |
| 3/6/2023 | Neutral → Sell | Compass Point | |
| 3/6/2023 | $9.00 → $4.00 | Neutral → Underperform | Wedbush |
| 3/2/2023 | $16.00 → $10.00 | Buy → Neutral | Compass Point |
| 3/2/2023 | Neutral → Underweight | JP Morgan |
Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00
Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00
BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00
GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026. About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a
Generates First Quarter Net Revenue Growth of 65% Year-Over-YearGRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026. First Quarter Financial HighlightsGenerated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025Achieved gross margin of 77.7% for the first quarter compare
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture IndicationsGRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX"). The commencement of full launch follows a successful limited market release and receipt of additional FDA 5
10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
DEF 14A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
Generates First Quarter Net Revenue Growth of 65% Year-Over-YearGRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026. First Quarter Financial HighlightsGenerated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025Achieved gross margin of 77.7% for the first quarter compare
GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti
Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y
GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board. "Drew is a proven healthcare leader, and we are thrilled to welcome him to S
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)